Tag:
Clolar
Latest Headlines
Latest Headlines
FDA panel wants new trial for Genzyme med
More bad news for Genzyme: Its leukemia drug Clolar probably won't get a new indication for adults anytime soon. An FDA advisory panel was less than impressed with the company's data supporting
FDA questions Genzyme study ahead of review
Federal regulators, set to hear from a panel of cancer experts on Genzyme's leukemia drug Clolar on Tuesday, indicated that the drugmaker's clinical data may not be sufficient. Clolar is approved to
FDA questions broader use of Genzyme's Clolar
FDA drug reviewers questioned a Genzyme study meant to back wider use of the company's Clolar leukemia drug, according to documents released ahead of an advisory panel review. Report
